Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MODY2”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)Ended earlyNCT01029795
What this trial is testing

LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 38
Not applicableUnknownNCT04091854
What this trial is testing

The Progress of Diabetes Mellitus After HMS5552 Treatment in Type 2 Diabetes Mellitus

Who this might be right for
Type2 Diabetes Mellitus
Majianhua 24
Very early researchLooking for participantsNCT06609356
What this trial is testing

Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes MellitusGlucokinase-Maturity Onset Diabetes of the Young (GCK-MODY)MODY2 Diabetes+1 more
Vanderbilt University Medical Center 27
Large-scale testing (Phase 3)Active Not RecruitingNCT05098470
What this trial is testing

Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity

Who this might be right for
Type 2 Diabetes
University of Alabama at Birmingham 100
Post-approval studies (Phase 4)WithdrawnNCT02198209
What this trial is testing

Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation

Who this might be right for
Type 2 Diabetes
Cedars-Sinai Medical Center
Early research (Phase 1)Study completedNCT01247363
What this trial is testing

LY2608204 in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 20
Not applicableLooking for participantsNCT06147414
What this trial is testing

Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders

Who this might be right for
Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, IncludingSickle Cell DiseaseCystic Fibrosis+12 more
Assistance Publique - Hôpitaux de Paris 550
Early research (Phase 1)Study completedNCT02077452
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HMS5552 in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Hua Medicine Limited 53
Testing effectiveness (Phase 2)Study completedNCT02405260
What this trial is testing

Add Glucokinase Activator to Target A1c

Who this might be right for
Diabetes Mellitus, Type 2
vTv Therapeutics 190
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06976658
What this trial is testing

Glucokinase Activator in Monogenic Diabetes

Who this might be right for
Diabetes MellitusMonogenic Diabetes
Chinese University of Hong Kong 44
Early research (Phase 1)Temporarily pausedNCT01472809
What this trial is testing

A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral ZYGK1 in Healthy Volunteers

Who this might be right for
Diabetes
Zydus Lifesciences Limited 96
Not applicableUnknownNCT01960231
What this trial is testing

The Effect of ß-cell Specific Glucokinase Mutation on Glucose Homeostasis and Insulin Secretion in a MODY-2 Family

Who this might be right for
MODY-2 Diabetes
Sheba Medical Center 30
Early research (Phase 1)Study completedNCT03414892
What this trial is testing

Multiple Ascending Doses of Globalagliatin Hydrochloride in Type 2 Diabetes Mellitus

Who this might be right for
Hyperglycaemia (Diabetic)Type 2 Diabetes Mellitus
Yabao Pharmaceutical Group 24
Testing effectiveness (Phase 2)Study completedNCT04516759
What this trial is testing

AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19

Who this might be right for
Covid19
St George Street Capital 170
Early research (Phase 1)Study completedNCT06498284
What this trial is testing

Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type II
Hua Medicine Limited 40
Early research (Phase 1)Study completedNCT03973515
What this trial is testing

Clinical Trial for the Investigational Drug (PB-201) in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type2 Diabetes Mellitus
PegBio Co., Ltd. 16
Early research (Phase 1)Study completedNCT02597400
What this trial is testing

Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM

Who this might be right for
Type 2 Diabetes Mellitus
Hua Medicine Limited 12
Not applicableNot Yet RecruitingNCT06671340
What this trial is testing

Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes

Who this might be right for
Diabetes MellitusPrediabetes / Type 2 Diabetes
Elaine Chow 30
Not applicableStudy completedNCT02556840
What this trial is testing

Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes

Who this might be right for
Maturity-Onset Diabetes of the Young
Assistance Publique - Hôpitaux de Paris 46
Early research (Phase 1)Study completedNCT02971202
What this trial is testing

Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2)

Who this might be right for
Type 1 Diabetes MellitusMaturity-Onset Diabetes of the Young, Type 2MODY2+1 more
Vanderbilt University 33